ABSTRACT
INTRODUCTION
The rise in Cesarean section (CS) rate observed in the past two decades has led to an increased incidence of abnormally invasive placenta (AIP) [1] [2] [3] [4] [5] [6] . AIP is characterized by abnormal insertion of the placenta into the implantation site. Three different types of AIP have been described according to the severity of placental invasion: placenta accreta, in which the chorionic villi adhere to the myometrium, without invading it; placenta increta, in which the villi invade the myometrium; and placenta percreta, in which there is full invasion of the myometrium and uterine serosa with the potential to reach adjacent organs, such as the bladder or bowel 1 . AIP is associated with maternal morbidity, such as severe life-threatening hemorrhage, need for blood transfusion, re-operation and damage to adjacent organs. Prenatal diagnosis of AIP is fundamental, and it has been reported to improve the outcome of affected women by allowing preplanned treatment of these conditions in centers with a high level of surgical expertise 7 . Prenatal diagnosis of AIP is usually accomplished by ultrasound, which has an overall good diagnostic accuracy in identifying AIP, whereas magnetic resonance imaging (MRI) is employed to confirm the diagnosis and to delineate the depth and the topography of placental invasion (AIP) 8, 9 . Despite this, prenatal diagnosis of AIP still needs to be standardized and has been reported to be highly variable among different centers. Furthermore, AIP can occur even in women with no classical risk factors such as placenta previa and prior CS, thus questioning which subset of women should be screened for these anomalies. Finally, although reported to be beneficial, the actual impact of prenatal diagnosis of AIP on maternal surgical outcome has not yet been quantified objectively.
The aim of this systematic review was to ascertain the impact of prenatal diagnosis on surgical outcome of women affected by AIP.
METHODS

Data sources
This review was performed according to an a-prioridesigned protocol recommended for systematic reviews and meta-analyses [10] [11] [12] . MEDLINE, EMBASE, CINAHL and the Cochrane Library, including the Cochrane Database of Systematic Reviews (CDSR), Database of Abstracts of Reviews of Effects (DARE) and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched electronically on 23 February 2017, utilizing combinations of the relevant medical subject heading (MeSH) terms, keywords and word variants for 'abnormally invasive placenta', 'morbidly adherent placenta', 'prenatal diagnosis' and 'outcome' (Table S1 ). The search and selection criteria were restricted to the English language. Reference lists of relevant articles and reviews were hand searched for additional reports. Prisma guidelines were followed 13 . The study was registered with the PROSPERO database (registration number: CRD42017069655).
Main outcomes and measures
The observed outcomes were: gestational age at birth (weeks); blood loss (L); units of red blood cells (RBC), platelets (PLT) and fresh frozen plasma (FFP) transfused; length of in-hospital stay (days); admission to intensive care unit; length of stay in ICU (days); rate of hysterectomy; use of interventional radiology; occurrence of coagulopathy; urinary tract injury (including bladder and ureteral injuries); need for re-operation; and infection. Furthermore, we aimed to stratify the analysis, according to histopathological confirmation of AIP and those affected by placenta previa and those affected by placenta percreta.
Eligibility criteria, study selection and data collection
Only case-control studies reporting on the occurrence of any of the explored outcomes in women with a prenatal compared with those with an intrapartum diagnosis of AIP were considered eligible for inclusion. Studies not reporting a control group and those without clear confirmation of AIP were excluded. Studies published before 2000 were excluded, as we considered that advances in prenatal imaging techniques and improvements in the diagnosis and definition of AIP make these less relevant. We planned to perform a sensitivity analysis including only cases affected by placenta percreta in view of the reported stronger association between this type of AIP and adverse maternal outcome compared with that with less severe types of placental invasion.
Prospective and retrospective case-control studies and case series were analyzed. Opinions, case series with fewer than four cases of AIP and case reports were also excluded in order to avoid publication bias.
Two reviewers (D.B., F.D.A.) extracted data independently. Inconsistencies were discussed by the reviewers and consensus reached. For those articles in which targeted information was not reported but the methodology was such that the information might have been recorded initially, the authors were contacted requesting the data. Histopathological findings and/or surgical notes were used as a gold standard.
Quality assessment of the included studies was performed using the Newcastle-Ottawa Scale (NOS) for case-control studies. According to NOS, each study is judged on three broad perspectives: selection of the study groups; the comparability of the groups; and the ascertainment of outcome of interest 13, 14 . Assessment of the selection of a study's groups includes the evaluation of the representativeness of the exposed cohort, selection of the non-exposed cohort, ascertainment of exposure and demonstration that outcome of interest was not present at the start of the study. Assessment of the comparability of the study includes evaluation of the comparability of cohorts based on the design or analysis. Finally, ascertainment of the outcome of interest includes the evaluation of the type of assessment of the outcome of interest, and length and adequacy of follow-up. According to NOS, a study can be awarded a maximum of one star for each numbered item within the Selection and Outcome categories. A maximum of two stars can be given for Comparability 14 .
Statistical analysis
First, we used random-effect head-to-head meta-analyses to compare the explored clinical outcomes in women with a prenatal diagnosis of AIP vs those in women with an intrapartum AIP diagnosis. Furthermore, we aimed to stratify the analysis, including only women affected by placenta previa, those affected by placenta percreta and those undergoing hysterectomy.
For each continuous outcome, results were expressed as a summary mean difference (MD) with 95% CI; for each categorical outcome, results were expressed as a summary odds ratio (OR) with 95% CI. Some of the continuous outcomes were expressed as medians and ranges; in such cases, we used the method described by Hozo et al. to obtain the corresponding means and SDs 15 . When interquartile ranges (IQRs) rather than ranges were reported, they were divided by 1.35 to obtain the equivalent SD 16 . In all meta-analyses, statistical heterogeneity was quantified using the I 2 metric. Second, meta-analyses of proportions were performed to estimate the pooled rates of each categorical outcome in women with a prenatal AIP diagnosis and in those with an intrapartum AIP diagnosis. In order to account for between-study heterogeneity, meta-analyses were performed using a random-effect model.
Assessment of potential publication bias was problematic because of the scarce number of studies. The formal tests for funnel plot asymmetry cannot be used when the total number of publications included for each outcome is less than 10, because its power is too low to distinguish chance from real asymmetry 17 . We were thus able to assess publication bias only in the meta-analysis comparing blood loss in women with a prenatal vs intrapartum diagnosis of AIP. We displayed the effect estimates of individual studies vs the logarithm of their standard errors (SE), and we performed Egger's regression asymmetry test 18 . 
RESULTS
General characteristics
A total of 1008 articles were identified. After screening the abstracts, 65 full-text articles were assessed with respect to their eligibility for inclusion (Table S2 ) and 13 studies were included in the systematic review (Table 1 and Figure 1 ) [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] . These 13 studies included 971 pregnancies affected by AIP; of these, 53.0% (95% CI, 50.8-57.3%; 514/971) were diagnosed prenatally by ultrasound or MRI, while 47.0% (95% CI, 44.8-51.3%; 457/971) were detected at the time of delivery. The prevalence of placenta previa was 91.4% (95% CI, 83.4-96.9%; I 2 = 82%) in the group with AIP detected prenatally, while it was 57.9% (95% CI, 39.0-75.6%; I 2 = 90.4%) in the group with an intrapartum diagnosis, with an OR of 12.0 (95% CI, 5.9-24.6; I 2 = 51%). Quality assessment of the included studies performed using the NOS for cohort studies is shown in Table 2 . Most of the included studies showed an overall good rating for selection and comparability of study groups. The main weaknesses of these studies were their retrospective design, small sample size and lack of stratification of the analysis according to severity of placental invasion for the majority of the included series.
Synthesis of results
Eleven studies, including 700 pregnancies, explored the difference in total blood loss during surgery in women with compared with those without a prenatal diagnosis of AIP. Women with a prenatal diagnosis of AIP had less blood loss during surgery (MD, −0.87 L; 95% CI, 22 Hall (2014) 23 Chantraine (2013) 24 Fitzpatrick (2014) 25 Tikkanen (2011) 26 Angstmann (2010) 27 Diop (2010) 28 Eller (2009) 29 Warshak (2010) 30 Bodner (2006) 31
Only first author of each study is given. Maximum of one star per numbered item in selection and outcome categories. Maximum of two stars for comparability. −1.5 to −0.23 L; P = 0.008). Likewise, the units of RBC (MD, −1.45; 95% CI, −2.9 to −0.04; P = 0.04) and FFP (MD, −1.73; 95% CI, −3.3 to −0.2; P = 0.03) transfused were fewer in women with a prenatal diagnosis of AIP compared with in those with an intrapartum diagnosis, while there was no difference in the number of units of PLT transfused during surgery between the two study groups. The risk of admission to ICU, and median lengths of in-hospital and in-ICU stay were not different between women with a prenatal and those with an intrapartum diagnosis of AIP (Tables 3 and 4) . Women with a prenatal diagnosis of AIP had higher risk of urinary tract injury during surgery (OR, 2.5; 95% CI, 1.3-4.6) and this was mainly due to the increased risk of bladder (OR, 2.2; 95% CI, 1.1-4.4; P = 0.02) rather than ureteral (P = 0.6) injury. The higher prevalence of placenta percreta in the group of women with a prenatal diagnosis of AIP is likely to account for this difference (OR, 5.5; 95% CI, 2.7-11.2; I 2 = 4.5%). Finally, there was no difference in the risk of coagulopathy during or immediately after surgery or in the risk of infection between the two groups (Table 4) .
Pooled prevalence of the different categorical outcomes explored in the present systematic review is reported in Table 5 .
The subanalysis considering only cases of placenta previa was affected by the small number of included cases, which might have precluded the power of the analysis. Overall, women with placenta previa who had AIP diagnosed prenatally had less mean blood loss compared with those who had an intraoperative diagnosis (MD, −0.684; 95% CI, −0.995 to −0.15; P = 0.008) (Tables S3 and S4 ).
DISCUSSION
The findings from this systematic review show that prenatal diagnosis of AIP is associated with reduced hemorrhagic morbidity than is detection at birth. Women with a prenatal diagnosis of AIP had less mean blood loss and fewer units of RBC and FFP transfused than did controls, suggesting a beneficial effect of prenatal imaging on maternal outcome in cases affected by AIP. The strengths of this study are its robust methodology for identifying all possible studies for inclusion, assessing data quality and synthesizing all suitable data.
The small number of included studies, their retrospective non-randomized design, heterogeneity in surgical management of AIP, presence of confounding factors potentially affecting the observed outcomes, and lack of stratification of the analysis according to maternal risk factors and severity of placental invasion represent the main limitations of the present systematic review. In addition, the prevalence of placenta percreta in the group with AIP diagnosed prenatally was higher than in those with intrapartum detection. In this scenario, the lack of differences reported in the present systematic review for some of the explored maternal outcomes might have been the result of such higher prevalence of percreta, thus representing a considerable source of bias.
Rise in CS rate over the past two decades has led obstetricians to be faced daily with AIP disorders 6 . Prenatal diagnosis of AIP has been reported to reduce the burden of intra-and perisurgical complications associated with these anomalies. Use of interventional radiology, a tailored surgical approach and prompt availability of blood products are likely to account for these differences and highlight the need for a standardized and multidisciplinary management in centers with high diagnostic and surgical expertise 7, 32 . Prenatal diagnosis of AIP is usually accomplished by ultrasound and has been reported to be accurate, especially when applied to women with anterior placenta previa and previous CS, while MRI is usually performed to confirm the diagnosis and to delineate the depth and topography of invasion 8, 9 . Despite this, prenatal detection of AIP has been reported to be highly variable among difference centers. Different gestational ages at assessment and type and number of ultrasound signs used to label a case as affected are likely to account for such heterogeneity. Multiparametric models including maternal, pregnancy and ultrasound characteristics have been shown to improve the prenatal detection of AIP, although they require confirmation in large population studies 33 . At present, the highest diagnostic performance of ultrasound is achieved in women with placenta previa and a prior CS, while its accuracy in those with other risk factors has still to be ascertained but is likely to be lower. These findings highlight the urgent need to standardize prenatal diagnosis of AIP and to stratify the risk of AIP prenatally. Until then, we think that every woman with placenta previa and at least one prior CS should be considered at high risk for AIP and referred to a center with high expertise in prenatal diagnosis of these anomalies.
In the present review, we found no difference in some of the explored outcomes, such as days of in-hospital or ICU stay and need for blood transfusion. The small number of cases included in some analyses may have precluded reaching adequate statistical power, thus explaining partially this lack of association. Furthermore, it is entirely possible that some women in the group with AIP detected at delivery might have been treated as if they were affected by these anomalies based on the presence of several risk factors, even if prenatal imaging assessment was negative.
The risk of bladder injury was higher in women with a prenatal diagnosis of AIP. Although this might seem surprising, such a difference can be explained on the basis that women with a prenatal diagnosis of AIP were more likely to be affected by placenta percreta, which is associated with a higher burden of surgical morbidity, compared with a lesser degree of invasion. Furthermore, the type of bladder injury was not specified in most of the original studies. Entry into the bladder is sometimes inevitable in case of placenta percreta, as is the need to remove portions of the bladder and/or ureters 32, 34 . In this scenario, the higher rate of urinary-tract injury observed in the group with AIP diagnosed before birth might have been the result of a conscious surgical approach rather than unexpected and unwanted complications.
Large randomized studies are needed in order to improve and standardize the prenatal diagnosis and management of AIP in order to allow women with antenatal suspicion of these anomalies to be followed up and managed in centers with a high level of expertise in the surgical management of these conditions.
